Qualitative changes in the proteome of extracellular vesicles accompanying cancer cell transition to mesenchymal state

Experimental Cell Research

Volumn 319, Issue 17, 2013, Pages 2747-2757

  Garnier, Delphine ^a   Magnus, Nathalie ^a   Meehan, Brian ^a   Kislinger, Thomas ^b   Rak, Janusz ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Cancer; Cancer stem cells; E cadherin; EGFR; EMT; Exosomes; Extracellular vesicles; Oncogenes; Proteome

Indexed keywords

ALPHA2 INTEGRIN; CD24 ANTIGEN; CD9 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; INTEGRIN; MEMBRANE PROTEIN; PROTEOME; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER STEM CELL; CELL GROWTH; CELL MOTION; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR VESICLE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84885372620     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.08.003     Document Type: Article

References (65)

1. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
2. Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
3. Liu Y., Zhou Y., Zhu K. Inhibition of glioma cell lysosome exocytosis inhibits glioma invasion. PLoS ONE 2012, 7:e45910.
4. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 2009, 9:265-273.
5. Tiwari N., Gheldof A., Tatari M., Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin. Cancer Biol. 2012, 22:194-207.
6. St C.B., Sheehan C., Rak J.W., Florenes V.A., Slingerland J.M., Kerbel R.S. E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J. Cell Biol. 1998, 142:557-571.
7. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 68:3645-3654.
8. Milsom C.C., Yu J.L., Mackman N., Micallef J., Anderson G.M., Guha A., Rak J.W. Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res. 2008, 68:10068-10076.
9. Garnier D., Magnus N., Lee T.H., Bentley V., Meehan B., Milsom C., Montermini L., Kislinger T., Rak J. Cancer cells induced to express mesenchymal phenotype release exosome-like extracellular vesicles carrying tissue factor. J. Biol. Chem. 2012, 287:43565-43572.
10. Luga V., Zhang L., Viloria-Petit A.M., Ogunjimi A.A., Inanlou M.R., Chiu E., Buchanan M., Hosein A.N., Basik M., Wrana J.L. Exosomes mediate stromal mobilization of autocrine Wnt-PCP Signaling in breast cancer cell migration. Cell 2012, 151:1542-1556.
11. Tauro B.J., Mathias R.A., Greening D.W., Gopal S.K., Ji H., Kapp E.A., Coleman B.M., Hill A.F., Kusebauch U., Hallows J.L., Shteynberg D., Moritz R.L., Zhu H.J., Simpson R.J. Oncogenic H-Ras reprograms Madin-Darby canine kidney (MDCK) cell-derived exosomal proteins following epithelial-mesenchymal transition. Mol. Cell. Proteomics 2013, 12:2148-2159.
12. Lee T.H., D'Asti E., Magnus N., Al-Nedawi K., Meehan B., Rak J. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin. Immunopathol. 2011, 33:455-467.
13. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009, 9:581-593.
14. Al-Nedawi K., Meehan B., Micallef J., Lhotak V., May L., Guha A., Rak J. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat. Cell Biol. 2008, 10:619-624.
15. Peinado H., Aleckovic M., Lavotshkin S., Matei I., Costa-Silva B., Moreno-Bueno G., Hergueta-Redondo M., Williams C., Garcia-Santos G., Ghajar C.M., Nitadori-Hoshino A., Hoffman C., Badal K., Garcia B.A., Callahan M.K., Yuan J., Martins V.R., Skog J., Kaplan R.N., Brady M.S., Wolchok J.D., Chapman P.B., Kang Y., Bromberg J., Lyden D. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 2012, 18:833-891.
16. Hood J.L., Pan H., Lanza G.M., Wickline S.A. Paracrine induction of endothelium by tumor exosomes. Lab. Invest. 2009, 89:1317-1328.
17. Antonyak M.A., Li B., Boroughs L.K., Johnson J.L., Druso J.E., Bryant K.L., Holowka D.A., Cerione R.A. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc. Nat. Acad. Sci. USA 2011, 108:4852-4857.
18. Deregibus M.C., Cantaluppi V., Calogero R., Lo I.M., Tetta C., Biancone L., Bruno S., Bussolati B., Camussi G. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007, 110:2440-2448.
19. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
20. Bobrie A., Krumeich S., Reyal F., Recchi C., Moita L.F., Seabra M.C., Ostrowski M., Thery C. Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res. 2012, 72:4920-4930.
21. Skog J., Wurdinger T., van R.S., Meijer D.H., Gainche L., Curry W.T., Carter B.S., Krichevsky A.M., Breakefield X.O. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10:1470-1476.
22. Russell T.B., Skinner A.M., Kurre P. Programmed vesicle transfer of green fluorescent protein from a stably transduced cell line to primary hematopoietic cells. Blood 2012, 119:5330-5332.
23. Bobrie A., Colombo M., Raposo G., Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011, 12:1659-1668.
24. Koumangoye R.B., Sakwe A.M., Goodwin J.S., Patel T., Ochieng J. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS ONE 2011, 6:e24234.
25. Hendrix A., Westbroek W., Bracke M., De W.O. An ex(o)citing machinery for invasive tumor growth. Cancer Res. 2010, 70:9533-9537.
26. Johnstone R.M. Exosomes biological significance: A concise review. Blood Cells Mol. Dis. 2006, 36:315-321.
27. Chairoungdua A., Smith D.L., Pochard P., Hull M., Caplan M.J. Exosome release of beta-catenin: a novel mechanism that antagonizes Wnt signaling. J. Cell Biol. 2010, 190:1079-1091.
28. Sheldon H., Heikamp E., Turley H., Dragovic R., Thomas P., Oon C.E., Leek R., Edelmann M., Kessler B., Sainson R.C., Sargent I., Li J.L., Harris A.L. New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes. Blood 2010, 116:2385-2394.
29. Verweij F.J., Middeldorp J.M., Pegtel D.M. Intracellular signaling controlled by the endosomal-exosomal pathway. Commun. Integr. Biol. 2012, 5:88-93.
30. Gross J.C., Chaudhary V., Bartscherer K., Boutros M. Active Wnt proteins are secreted on exosomes. Nat. Cell Biol. 2012, 14:1036-1045.
31. Bolukbasi M.F., Mizrak A., Ozdener G.B., Madlener S., Strobel T., Erkan E.P., Fan J.B., Breakefield X.O., Saydam O. miR-1289 and "Zipcode" -like sequence enrich mRNAs in microvesicles. Mol. Ther. Nucleic Acids 2012, 1:e10. (e10). 10.1038/mtna.2011.2.
32. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
33. Yu J., May L., Milsom C., Anderson G.M., Weitz J.I., Luyendyk J.P., Broze G., Mackman N., Rak J. Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1975-1981.
34. Bianco F., Perrotta C., Novellino L., Francolini M., Riganti L., Menna E., Saglietti L., Schuchman E.H., Furlan R., Clementi E., Matteoli M., Verderio C. Acid sphingomyelinase activity triggers microparticle release from glial cells. EMBO J. 2009, 28:1043-1054.
35. Magnus N., Garnier D., Rak J. Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. Blood 2010, 116:815-818.
36. Sodek K.L., Evangelou A.I., Ignatchenko A., Agochiya M., Brown T.J., Ringuette M.J., Jurisica I., Kislinger T. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol. Biosyst. 2008, 4:762-773.
37. Craig R., Beavis R.C. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004, 20:1466-1467.
38. Kislinger T., Cox B., Kannan A., Chung C., Hu P., Ignatchenko A., Scott M.S., Gramolini A.O., Morris Q., Hallett M.T., Rossant J., Hughes T.R., Frey B., Emili A. Global survey of organ and organelle protein expression in mouse: combined proteomic and transcriptomic profiling. Cell 2006, 125:173-186.
39. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal. Chem. 2004, 76:4193-4201.
40. Marotta L.L., Almendro V., Marusyk A., Shipitsin M., Schemme J., Walker S.R., Bloushtain-Qimron N., Kim J.J., Choudhury S.A., Maruyama R., Wu Z., Gonen M., Mulvey L.A., Bessarabova M.O., Huh S.J., Silver S.J., Kim S.Y., Park S.Y., Lee H.E., Anderson K.S., Richardson A.L., Nikolskaya T., Nikolsky Y., Liu X.S., Root D.E., Hahn W.C., Frank D.A., Polyak K. The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J. Clin. Invest. 2011, 121:2723-2735.
41. Oliveras-Ferraros C., Vazquez-Martin A., Cufi S., Queralt B., Baez L., Guardeno R., Hernandez-Yague X., Martin-Castillo B., Brunet J., Menendez J.A. Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux) efficacy in KRAS wild-type tumor cells. J. Cell. Biochem. 2011, 112:10-29.
42. Geng S., Guo Y., Wang Q., Li L., Wang J. Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma. Arch. Dermatol. Res. 2013, 305:35-47.
43. Bobrie A., Thery C. Exosomes and communication between tumours and the immune system: are all exosomes equal?. Biochem. Soc. Trans. 2013, 41:263-267.
44. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2011, D1241-4.
45. Kalra H., Simpson R.J., Ji H., Aikawa E., Altevogt P., Askenase P., Bond V.C., Borras F.E., Breakefield X., Budnik V., Buzas E., Camussi G., Clayton A., Cocucci E., Falcon-Perez J.M., Gabrielsson S., Gho Y.S., Gupta D., Harsha H.C., Hendrix A., Hill A.F., Inal J.M., Jenster G., Kramer-Albers E.M., Lim S.K., Llorente A., Lotvall J., Marcilla A., Mincheva-Nilsson L., Nazarenko I., Nieuwland R., Nolte-'t Hoen E.N., Pandey A., Patel T., Piper M.G., Pluchino S., Prasad T.S., Rajendran L., Raposo G., Record M., Reid G.E., Sanchez-Madrid F., Schiffelers R.M., Siljander P., Stensballe A., Stoorvogel W., Taylor D., Thery C., Valadi H., van Balkom B.W., Vazquez J., Vidal M., Wauben M.H., Yanez-Mo M., Zoeller M., Mathivanan S. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012, 10:e1001450.
46. Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 2005, 5:744-749.
47. Hood J.L., San R.S., Wickline S.A. Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Res. 2011, 71:3792-3801.
48. Shao H., Chung J., Balaj L., Charest A., Bigner D.D., Carter B.S., Hochberg F.H., Breakefield X.O., Weissleder R., Lee H. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. J. Extracellular Vesicles 2012, 1:26.
49. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
50. Jung T., Castellana D., Klingbeil P., Cuesta H., I, Vitacolonna M., Orlicky D.J., Roffler S.R., Brodt P., Zoller M. CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 2009, 11:1093-1105.
51. Poste G., Nicolson G.L. Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc. Nat. Acad. Sci. USA 1980, 77:399-403.
52. Hao S., Ye Z., Li F., Meng Q., Qureshi M., Yang J., Xiang J. Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp. Oncol. 2006, 28:126-131.
53. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003, 3:347-361.
54. Lin K., Baritaki S., Militello L., Malaponte G., Bevelacqua Y., Bonavida B. The role of B-RAF mutations in melanoma and the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/PTEN circuit. Genes Cancer 2010, 1:409-420.
55. Palumbo J.S., Talmage K.E., Massari J.V., La Jeunesse C.M., Flick M.J., Kombrinck K.W., Hu Z., Barney K.A., Degen J.L. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 2007, 110:133-141.
56. Versteeg H.H., Schaffner F., Kerver M., Petersen H.H., Ahamed J., Felding-Habermann B., Takada Y., Mueller B.M., Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008, 111:190-199.
57. Thaler J., Ay C., Mackman N., Bertina R.M., Kaider A., Marosi C., Key N.S., Barcel D.A., Scheithauer W., Kornek G., Zielinski C., Pabinger I. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients. J. Thromb. Haemost. 2012, 10:1363-1370.
58. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., Marquez-Curtis L., Machalinski B., Ratajczak J., Ratajczak M.Z. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int. J. Cancer 2005, 113:752-760.
59. Hakulinen J., Sankkila L., Sugiyama N., Lehti K., Keski-Oja J. Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J. Cell. Biochem. 2008, 105:1211-1218.
60. Maschler S., Wirl G., Spring H., Bredow D.V., Sordat I., Beug H., Reichmann E. Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 2005, 24:2032-2041.
61. Misra A., Pandey C., Sze S.K., Thanabalu T. Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT). PLoS ONE 2012, 7:e49766.
62. Park J.E., Tan H.S., Datta A., Lai R.C., Zhang H., Meng W., Lim S.K., Sze S.K. Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol. Cell. Proteomics 2010, 9:1085-1099.
63. Simona F., Laura S., Simona T., Riccardo A. Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives. Proteomics 2013, 13:1581-1594.
64. Simpson R.J., Lim J.W., Moritz R.L., Mathivanan S. Exosomes: proteomic insights and diagnostic potential. Expert Rev. Proteomics 2009, 6:267-283.
65. M.C. Henderson, D.O. Azorsa, The genomic and proteomic content of cancer cell-derived exosomes, Front. Oncol., 2:38, Epub, 17 April 2012, 38.